Business & Operations

Drafts U.S. corporate transaction Letters of Intent (LOI) for mergers, acquisitions, investments, and strategic alliances. Separates non-binding intent from enforceable obligations and defines deal structure, key economics, and closing path. Use when converting deal terms into a preliminary transaction document. Trigger keywords: "LOI", "letter of intent", "M&A LOI", "merger term sheet", "no-shop", "exclusivity", "deal letter".

Generates structured litigation strategy summaries synthesizing case facts, legal arguments, procedural tactics, and risk assessments into a unified roadmap. Use when aligning legal teams on case direction, preparing for strategy meetings, or onboarding stakeholders to litigation matters.

Generate a response to a common legal inquiry using configured templates, with built-in escalation checks for situations that shouldn't use a templated reply. Use when responding to data subject requests, litigation hold notices, vendor legal questions, NDA requests from business teams, or subpoenas.

Drafts formal legal opinion letters for corporate and transactional matters with jurisdiction-specific analysis, calibrated conclusion language, and comprehensive qualifications. Use when drafting closing opinion letters, third-party reliance opinions, enforceability opinions, or corporate authority opinions for mergers, acquisitions, financings, or regulatory compliance.

Drafts professional legal letters for personal injury litigation including settlement demands, cease-and-desist, notice letters, and response correspondence. Tailors tone by recipient type. Use when drafting demand letters, pre-suit correspondence, insurance claim letters, cease-and-desist notices, or litigation response letters.

Drafts a mutual early lease termination agreement for U.S. commercial and residential properties. Covers party identification, termination mechanics, property surrender, financial settlement (prorated rent, security deposit accounting), mutual release with carve-outs, and execution formalities. Use when landlord and tenant agree to end a lease before expiration, when negotiating buyout terms, or resolving disputes through consensual termination.

Summarizes U.S. commercial lease agreements into structured transactional abstracts. Use when asked for a commercial lease summary, lease abstract, key lease terms, rent schedule review, default/termination analysis, or lease handoff. Produces party-to-obligation mappings, financial mechanics, risk flags, and critical date calendars.

Drafts unconditional guaranty agreements for commercial lease obligations, maximizing landlord protection with enforceable payment-and-performance guarantees. Use when securing personal or corporate guarantees alongside commercial leases, preparing continuing guaranty documents, or drafting guarantor waiver and liability provisions.

Drafts and structures U.S. Last Will and Testament documents. Trigger when the user needs to draft, revise, or review a will covering executor/guardian appointments, specific or residuary distributions, contingency planning, or execution-ready attestation and self-proving packaging. Applies to keywords: last will, testament, probate, executor, guardian, residuary, revocation, no-contest, ademption, predeceased beneficiary, elective share.

Drafts Know-How License Agreements for licensing trade secrets, confidential processes, and proprietary methodologies where value derives from secrecy rather than patents. Reviews transaction documents to extract deal terms, financial structures, and exclusivity provisions. Use when drafting know-how licenses, trade secret licenses, technology transfer agreements, or confidential information licensing agreements.

Drafts U.S. know-how (trade secret) license agreements covering scope, exclusivity, field-of-use, territory, consideration, confidentiality, tech transfer, diligence, and compliance. Use when licensing confidential technical information, manufacturing processes, trade secrets, non-patent IP, or process know-how; trigger keywords: know-how license, trade secret license, technology transfer agreement, confidential information license, process license, technical know-how, manufacturing know-how.

Drafts U.S. Joint Operating Agreements (JOA) for oil and gas exploration, development, and production. Covers party structure, operator authority, AFE workflow, cost allocation, billing and audit rights, title and lien protections, default remedies, and governing-law provisions. Use when drafting, negotiating, or finalizing a JOA, joint account agreement, non-consent election, operator designation, participating interest schedule, or memorandum of operating agreement.

Drafts a tabletop exercise script to stress-test an organization's Incident Response Plan against cybersecurity threats and breach notification obligations (GDPR, CCPA, HIPAA, GLBA, PCI DSS, NERC CIP, DFARS, SEC). Produces scenario injects, participant role assignments, facilitation guides, and after-action report frameworks. Use when creating IR tabletop exercises, cybersecurity drills, breach response simulations, or incident preparedness assessments.

Summarizes and analyzes a U.S. corporate IP portfolio covering patents, trademarks, copyrights, and trade secrets. Use when conducting an IP audit, due diligence review, M&A assessment, licensing strategy, executive briefing, or portfolio optimization.

Drafts a U.S. Investors' Rights Agreement for VC/private equity financings, covering registration rights, information/management rights, pro rata rights, expenses, and termination. Use when drafting an IRA, Amended and Restated IRA, or VC financing governance package. Trigger keywords: "investors' rights agreement", "IRA", "registration rights", "piggyback", "Form S-3", "information rights", "management rights", "pro rata", "ROFO".

Drafts a U.S. Investment Advisory Agreement (IAA) for SEC- or state-registered advisers under the Investment Advisers Act of 1940, SEC Rules 204-3, 206(4)-2, and 206(4)-3. Use when onboarding an advisory client, establishing a new advisory relationship, or updating an existing IAA.

Drafts Investigator Agreements for FDA-regulated clinical trials between sponsors and principal investigators. Covers 21 CFR Parts 50, 56, 312/812, ICH GCP E6(R2), IRB governance, data integrity, IP, indemnification, financial terms, and termination. Use when preparing clinical trial investigator agreements, site agreements, PI agreements, or sponsor-investigator contracts for drug, biologic, or device studies.

Produces structured antitrust investigation summaries for executives and counsel. Triggers on FTC/DOJ probes, state AG investigations, foreign competition authority inquiries, merger investigations, CIDs, subpoenas, or dawn-raid responses.

Drafts a U.S. Confidentiality and Invention Assignment Agreement (CIAA/PIIA) for employee or contractor onboarding. Covers confidential information, DTSA immunity notices, state-specific invention assignment carve-outs (CA, DE, IL, KS, MN, NC, UT, WA), present-tense IP assignment, work-made-for-hire, restrictive covenants, and prior invention disclosure. Use when drafting IP assignment agreements, onboarding employees or contractors, or protecting trade secrets in employment contexts. Trigger...

Drafts a Phase II invasive testing consent letter that limits scope, locations, timing, data control, restoration, security, and risk allocation under an existing access, due diligence, or purchase and sale agreement. Use this skill when a counterparty requests soil borings, test pits, groundwater wells, soil vapor sampling, or other intrusive ESA activities. Trigger on keywords including "Phase II," "invasive testing," "environmental site assessment," "ESA," "borings," "test pits," "monitori...

Produces a compliance memo and execution plan for U.S. intrastate securities offerings under Rule 147 or Rule 147A with state registration by qualification. Covers safe harbor selection, doing-business tests, residency verification, advertising controls, resale restrictions, integration analysis, and blue sky registration. Trigger when the user mentions intrastate offering, Rule 147, Rule 147A, registration by qualification, single-state offering, Section 3(a)(11), state-only fundraising, in-...

Structures drug screen interpretation with confirmation testing and clinical correlation. Use when interpreting drug screens, managing confirmatory testing, or documenting toxicology results.

Analyzes comprehensive metabolic panels, CBCs, lipid panels, and thyroid function with clinical correlation. Use when reviewing outpatient labs, identifying abnormalities, or correlating lab trends.

Structures brain and spine imaging interpretation with stroke, mass, and degenerative disease assessment. Use when reading neuroimaging, evaluating stroke imaging, or documenting intracranial findings.